- Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland
- Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Adivsory Committee on Immunization Practices – United States, june 2021
- SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis
- Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents